The WHO guidelines: the new and the old

Author:

Thompson Jo1

Affiliation:

1. Supportive & Palliative Care, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK

Abstract

Purpose of the review The original World Health Organisation (WHO) cancer pain guidelines were published in 1986 and used globally. Updated guidance was released in 2018. This review compares the ‘old’ with the ‘new’ with a closer look at the relevance of the WHO analgesic ladder in the current climate. Recent findings The new guidelines provide a more evidence based, rigorously developed document including recommendations relating to radiotherapeutic management. There is a more detailed focus on safe opioid prescribing, opioid stewardship and the importance of integrating pain management expertise early on in the cancer journey. There remains a lack of evidence for certain therapies despite their widespread use particularly in relation to adjuvants. The pitfalls of the original renowned analgesic ladder are highlighted including a recognition that omitting ‘step 2’ is safe, feasible and cost effective. Summary The new guidelines offer more detailed recommendations relevant to clinical practice with a strong focus on safety of opioid prescribing making it relevant in the current climate. The original WHO analgesic ladder is no longer recommended as a strict protocol for cancer pain management.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference37 articles.

1. Is the WHO analgesic ladder still valid? Twenty-four years of experience;Vargus-Schaffer;Can Fam Physician,2010

2. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline;Paice;J Clin Oncol,2022

3. Standards for the management of cancer-related pain across Europe – a position paper from the EFIC task force on cancer pain;Bennett;Eur J Pain,2019

4. Supportive care: an indispensable component of modern oncology;Berman;Clin Oncol (R Coll Radiol),2020

5. The rise of supportive oncology: a revolution in cancer care;Berman;Clin Oncol (R Coll Radiol),2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3